Literature DB >> 20463417

A review of insulin pen devices.

Emily K McCoy1, Bradley M Wright.   

Abstract

Optimization of glycemic control is a fundamental aspect of diabetes management, and rates of diabetes-related microvascular complications are significantly decreased when glycemic control is improved. Currently, > 5 million Americans require insulin therapy to manage their diabetes, and this number is expected to multiply as the prevalence of type 2 diabetes increases secondary to several factors. The distinct pharmacodynamic properties of each insulin product help physicians decide which type of insulin is the most appropriate for each patient. The method of delivery that will ensure both patient and provider satisfaction must also be carefully considered. Insulin pen devices are designed to provide a convenient and easy means of insulin administration for the patient and can be divided into 2 categories: the reusable, durable pen, and the disposable, prefilled pen. These insulin pen devices are an alternative to the traditional insulin vial-and-syringe method and offer many advantages. Insulin pens have also been found to be less painful than the vial-and-syringe method and are often associated with greater patient preference and social acceptability. As a result, this method of insulin delivery may ultimately help to improve glycemic control and should be considered when prescribing insulin products.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463417     DOI: 10.3810/pgm.2010.05.2145

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  8 in total

1.  Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen.

Authors:  David Klonoff; Irina Nayberg; Ivana Rabbone; Catherine Domenger; Udo Stauder; Hamid Oualali; Thomas Danne
Journal:  J Diabetes Sci Technol       Date:  2015-01-28

Review 2.  Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.

Authors:  David C Klonoff; Irina Nayberg; Udo Stauder; Hamid Oualali; Catherine Domenger
Journal:  J Diabetes Sci Technol       Date:  2016-11-28

3.  Analysis of "Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen".

Authors:  Mallika Bariya; Irina Nayberg
Journal:  J Diabetes Sci Technol       Date:  2017-12-27

4.  Comparison of patient satisfaction with two different etanercept delivery systems. A randomised controlled study in patients with rheumatoid arthritis.

Authors:  U Müller-Ladner; R M Flipo; P Vincendon; Y Brault; D Kielar
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

5.  Implantable batteryless device for on-demand and pulsatile insulin administration.

Authors:  Seung Ho Lee; Young Bin Lee; Byung Hwi Kim; Cheol Lee; Young Min Cho; Se-Na Kim; Chun Gwon Park; Yong-Chan Cho; Young Bin Choy
Journal:  Nat Commun       Date:  2017-04-13       Impact factor: 14.919

6.  Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen.

Authors:  Christopher M Kappes; James R Kershner; Tina M Morwick; Sheila M Corrigan
Journal:  J Diabetes Sci Technol       Date:  2017-10-30

7.  Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector (AI) and Pre-Filled Syringe (PFS) of SB4 in Healthy Subjects.

Authors:  Donghoon Shin; Younsoo Kim; Ahra Go; Maria Velinova
Journal:  Drug Des Devel Ther       Date:  2020-01-08       Impact factor: 4.162

Review 8.  The Review of Insulin Pens-Past, Present, and Look to the Future.

Authors:  Małgorzata Masierek; Katarzyna Nabrdalik; Oliwia Janota; Hanna Kwiendacz; Maksymilian Macherski; Janusz Gumprecht
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.